118 related articles for article (PubMed ID: 2027527)
21. Afferent effects on locus coeruleus in opiate withdrawal.
Rasmussen K
Prog Brain Res; 1991; 88():207-16. PubMed ID: 1839935
[TBL] [Abstract][Full Text] [Related]
22. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
23. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
25. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
26. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
27. Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice.
Ninan I; Kulkarni SK
Brain Res; 2000 Sep; 876(1-2):215-9. PubMed ID: 10973613
[TBL] [Abstract][Full Text] [Related]
28. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
Maldonado R; Girdlestone D; Roques BP
Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
[TBL] [Abstract][Full Text] [Related]
29. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
30. A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant/dependent rat brain.
Fry JP; Herz A; Zieglgänsberger W
Br J Pharmacol; 1980 Mar; 68(3):585-92. PubMed ID: 6132637
[TBL] [Abstract][Full Text] [Related]
31. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input.
Akaoka H; Aston-Jones G
J Neurosci; 1991 Dec; 11(12):3830-9. PubMed ID: 1683899
[TBL] [Abstract][Full Text] [Related]
32. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Farzin D
Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
[TBL] [Abstract][Full Text] [Related]
33. The N-methyl-D-aspartate-mediated inhibitory control of gonadotropin-releasing hormone release in the hypothalamus of the adult male guinea pig is expressed through opioidergic systems.
Giri M; Gao C; Kaufman JM
Endocrinology; 1996 Apr; 137(4):1468-73. PubMed ID: 8625925
[TBL] [Abstract][Full Text] [Related]
34. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
35. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence.
Fundytus ME; Coderre TJ
Br J Pharmacol; 1994 Dec; 113(4):1215-20. PubMed ID: 7889275
[TBL] [Abstract][Full Text] [Related]
36. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome.
Tokuyama S; Wakabayashi H; Ho IK
Eur J Pharmacol; 1996 Jan; 295(2-3):123-9. PubMed ID: 8720575
[TBL] [Abstract][Full Text] [Related]
37. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
[TBL] [Abstract][Full Text] [Related]
38. Role of excitatory amino acid receptors in K+- and glutamate-evoked release of endogenous adenosine from rat cortical slices.
Hoehn K; White TD
J Neurochem; 1990 Jan; 54(1):256-65. PubMed ID: 1967143
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
40. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
